Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis

Detalles Bibliográficos
Autores principales: Mokhtari, Reza Bayat, Qorri, Bessi, Baluch, Narges, Sparaneo, Angelo, Fabrizio, Federico Pio, Muscarella, Lucia Anna, Tyker, Albina, Kumar, Sushil, Cheng, Hai-Ling Margaret, Szewczuk, Myron R., Das, Bikul, Yeger, Herman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450989/
https://www.ncbi.nlm.nih.gov/pubmed/36093295
http://dx.doi.org/10.18632/oncotarget.28104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450989/
https://www.ncbi.nlm.nih.gov/pubmed/36093295
http://dx.doi.org/10.18632/oncotarget.28104

Ejemplares similares